Date,Agency,Category,Title,Link
 30. June 2025,MedTech Leading Voice,Roundup,Regulatory Roundup 30. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7345405781271359488?
 30. June 2025,Team-NB,Position Paper,Code of Conduct for Notified Bodies under Regulations (EU) 2017/745 and (EU) 2017/746,https://www.linkedin.com/feed/update/urn:li:activity:7345371736739078146?
 30. June 2025,Team-NB,Position Paper,Software classification under the IVDR V2,https://www.linkedin.com/feed/update/urn:li:activity:7345329303665930240? 
 30. June 2025,MedTech Leading Voice,Newsletter,EU AI Act,https://www.linkedin.com/feed/update/urn:li:activity:7345306735047262208?
 30. June 2025,European Commission,Guidance,EUDAMED Production Release 2.15.0,https://www.linkedin.com/feed/update/urn:li:activity:7345365726276251648? 
30. June 2025,ANVISA Brazil,Report,Clinical Research of Drugs and Biological Products,https://www.linkedin.com/feed/update/urn:li:activity:7343524329642467329?
30. June 2025,Egyptian Drug Authority,Guidance,Issuing a notification for import approval or a letter of lack of competence,
30. June 2025,European Commission,Status Overview,Overview of CABs/NBs at each stage of the designation process,https://www.linkedin.com/feed/update/urn:li:activity:7341848915182338053?
30. June 2025,European Commission,Regulation,(EU) 2021/2226 medical devices IFU may be provided in electronic form,https://www.linkedin.com/feed/update/urn:li:activity:7343986300032626688?
30. June 2025,European Medicines Agency,Guidance,Expert decision and opinion Clinical Evaluation Consultation Procedure (CECP),https://www.linkedin.com/feed/update/urn:li:activity:7343908377736998913?
30. June 2025,Health Canada,Guidance,New requirements for second language product monographs and package insert,
30. June 2025,Health Canada,Guidance,"Submission information for biologic drugs (Division 4,Schedule D)",https://www.linkedin.com/feed/update/urn:li:activity:7343548592986488833?
30. June 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,Parallel Imports of Human Medicines,
30. June 2025,"Health Sciences Authority (HSA),Singapore",Guidance,"Introducing ""SHARE"" - Your digital portal for Medical Devices",https://www.linkedin.com/feed/update/urn:li:activity:7343505906417983488? 
30. June 2025,International Council for Harmonisation,Guidance,ICH E20 Adaptive Designs for Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7343912240258932738?
30. June 2025,International Council for Harmonisation,Guidance,ICH M4Q(R2) Step 2 Presentation Now Available on the ICH Website,
30. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Airlock: the regulatory sandbox for AIaMD,https://www.linkedin.com/feed/update/urn:li:activity:7342854372608909313?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Introducing new medicines in the NHS in the UK pathway,https://www.linkedin.com/feed/update/urn:li:activity:7342864280775536640?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Report,Business Plan 2025-2026,
30. June 2025,Medicines and Healthcare products Regulatory Agency,Report,MHRA Corporate Plan 2023-26,
30. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Medicines: clinical trials hub,
30. June 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Guidance,In Vitro Diagnostic Reagents Exempted from Clinical Trials (2025) (No. 23 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7343197289072517121?
30. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
30. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Application to import,supply,or export,non-compliant medical devices",https://www.linkedin.com/feed/update/urn:li:activity:7343179383840366592?
30. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Determining if your product is a cosmetic,a biological or a blood component",https://www.linkedin.com/feed/update/urn:li:activity:7344244654877425665?
30. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Medical devices exempt from PFAS ban,https://www.linkedin.com/feed/update/urn:li:activity:7344243141807357958?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Q1 Stability Testing of Drug Substances and Drug Products,https://www.linkedin.com/feed/update/urn:li:activity:7343174428660232193?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Early Lyme Disease as Manifested by Erythema Migrans,https://www.linkedin.com/feed/update/urn:li:activity:7343910438222409729?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Questions and Answers,https://www.linkedin.com/feed/update/urn:li:activity:7344257468845240322?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Unique Device Identifier Requirements for Combination Products,https://www.linkedin.com/feed/update/urn:li:activity:7344257085473275906?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Cybersecurity in Medical Devices: Quality System Considerations,https://www.linkedin.com/feed/update/urn:li:activity:7344256677514297344?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Antibacterial Therapies for Patients With an Unmet Medical Need Q&A,https://www.linkedin.com/feed/update/urn:li:activity:7344256310558777345?
30. June 2025,USA Food & Drug Administration FDA,Whitepaper,Securing Technology and Equipment Used for Medical Product Manufacturing,https://www.linkedin.com/feed/update/urn:li:activity:7344283687003324416?
28. June 2025,MedTech Leading Voice,Video,The QA/RA Week That Was 28. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7344682532711399424?
27. June 2025,MedTech Leading Voice,Roundup,Video Preview Regulatory Roundup 30. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7344410176369664001?
27. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Determining if your product is a cosmetic,a biological or a blood component",https://www.linkedin.com/feed/update/urn:li:activity:7344244654877425665?
27. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Medical devices exempt from PFAS ban,https://www.linkedin.com/feed/update/urn:li:activity:7344243141807357958?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Questions and Answers,https://www.linkedin.com/feed/update/urn:li:activity:7344257468845240322?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Unique Device Identifier Requirements for Combination Products,https://www.linkedin.com/feed/update/urn:li:activity:7344257085473275906?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7344256677514297344?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases Questions and Answers,https://www.linkedin.com/feed/update/urn:li:activity:7344256310558777345?
27. June 2025,USA Food & Drug Administration FDA,Whitepaper,Securing Technology and Equipment (Operational Technology) Used for Medical Product Manufacturing,https://www.linkedin.com/feed/update/urn:li:activity:7344283687003324416?
26. June 2025,European Commission,Regulation,(EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form,https://www.linkedin.com/feed/update/urn:li:activity:7343986300032626688?
26. June 2025,International Council for Harmonisation,Guidance,ICH E20 Adaptive Designs for Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7343912240258932738?
26. June 2025,USA Food & Drug Administration FDA,Guidance,Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment,https://www.linkedin.com/feed/update/urn:li:activity:7343910438222409729?
26. June 2025,European Commission,Guidance,"Expert decision and opinion in the context of the Clinical Evaluation Consultation Procedure (CECP) Expert panels on medical devices and in vitro diagnostic devices (Expamed)
Mechanical Ventilator,Class IIb:",https://www.linkedin.com/feed/update/urn:li:activity:7343908377736998913?
25. June 2025,MedTech Leading Voice,Guidance,Video: How to Use GPT AI to assist with creating an Intended Use Statement,https://www.linkedin.com/feed/update/urn:li:activity:7343533459954425856?
25. June 2025,MedTech Leading Voice,Guidance,Flipbook: How to Use GPT AI to assist with creating an Intended Use Statement,https://www.linkedin.com/feed/update/urn:li:activity:7343533436239769600?
30. June 2025,Health Canada,Guidance,"Guidance document on submission information for biologic drugs (Division 4,Schedule D): Overview",https://www.linkedin.com/feed/update/urn:li:activity:7343548592986488833?
30. June 2025,ANVISA Brazil,Report,8th Annual Report on Clinical Research of Drugs and Biological Products,https://www.linkedin.com/feed/update/urn:li:activity:7343524329642467329?
30. June 2025,"Health Sciences Authority (HSA),Singapore",Guidance,Introducing 'SHARE' - Your digital portal for Medical Devices,https://www.linkedin.com/feed/update/urn:li:activity:7343505906417983488? 
30. June 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Guidance,In Vitro Diagnostic Reagents Exempted from Clinical Trials (2025) (No. 23 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7343197289072517121?
30. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Viewing and responding to a notification from the dashboard about an application for consent to import,supply or export medical devices that do not meet the Essential Principles",https://www.linkedin.com/feed/update/urn:li:activity:7343179383840366592?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Q1 Stability Testing of Drug Substances and Drug Products,https://www.linkedin.com/feed/update/urn:li:activity:7343174428660232193?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Introducing new medicines in the NHS in the UK - pathway,https://www.linkedin.com/feed/update/urn:li:activity:7342864280775536640?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,AI Airlock: the regulatory sandbox for AIaMD,https://www.linkedin.com/feed/update/urn:li:activity:7342854372608909313?
22. June 2025,MedTech Leading Voice,Newsletter,MDSAP Enters a New Era,https://www.linkedin.com/feed/update/urn:li:activity:7342781461676126209?
21. June 2025,European Commission,Overview,Overview of CABs/NBs at each stage of the designation process,https://www.linkedin.com/feed/update/urn:li:activity:7341848915182338053?
20. June 2025,MedTech Leading Voice,Roundup,Video Preview Regulatory Roundup 23. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7341813319210610688?
19. June 2025,MedTech Leading Voice,Guidance,How to Use GPT AI to assist with an FMEA,https://www.linkedin.com/feed/update/urn:li:activity:7341539017978478595?
23. June 2025,Egyptian Drug Authority,Consultation,Requirements for manufacturing companies (IVD reagents/medical supplies),
23. June 2025,European Commission,Guidance,MDCG 2019-11 Rev.1 Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 MDR and Regulation (EU) 2017/746 IVDR,https://www.linkedin.com/feed/update/urn:li:activity:7340963175967739905?
23. June 2025,European Commission,Guidance,MDCG 2025-4 - Guidance on the safe making available of medical device software (MDSW) apps on online platforms (June 2025),https://www.linkedin.com/feed/update/urn:li:activity:7340602844833579008? 
23. June 2025,European Commission,Guidance,MDCG 2025-5 Questions & Answers regarding performance studies of in vitro diagnostic medical devices under regulation (EU) 2017/746,https://www.linkedin.com/feed/update/urn:li:activity:7341050283570982914?
23. June 2025,European Commission,Guidance,MDCG 2025-6 Interplay between the EU MDR EU IVDR and EU AI Act,https://www.linkedin.com/feed/update/urn:li:activity:7341688929370226691?
23. June 2025,European Medicines Agency,Guidance,Abbreviations used in EMA scientific committees & CMD documents,https://www.linkedin.com/feed/update/urn:li:activity:7340967046463057920?
23. June 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 16-19 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7341820248607649794?
23. June 2025,European Medicines Agency,Meeting,EMA Management Board: highlights of June 2025 meeting,https://www.linkedin.com/feed/update/urn:li:activity:7340659243701731329?
23. June 2025,European Medicines Agency,Guidance,Questions and Answers about the SEND proof-of-concept for industry,https://www.linkedin.com/feed/update/urn:li:activity:7340649173337149441? 
23. June 2025,European Medicines Agency,Guidance,Questions and answers for biological medicinal products,
23. June 2025,European Medicines Agency,Guidance,Quick guide for UPD notifications via the User interface and via email,
23. June 2025,European Medicines Agency,Guidance,Use of real-world data in non interventional studies for regulatory purposes,https://www.linkedin.com/feed/update/urn:li:activity:7340970629661110272?
23. June 2025,Health Canada,Bulletin,Cancellation of MDELs for non-compliance with annual licence review requirements:2025,https://www.linkedin.com/feed/update/urn:li:activity:7340260578713608192?
23. June 2025,Health Canada,Guidance,Data Protection under C.08.004.1 of the Food and Drug Regulations,https://www.linkedin.com/feed/update/urn:li:activity:7341707162584293376?
23. June 2025,ISO (International Organization for Standardization),Standards,ISO Update May 1. 2025 to June 1. 2025,https://www.linkedin.com/feed/update/urn:li:activity:7340655229979242496?
23. June 2025,Martin King,Guidance,How can GPT AI assist in building an FMEA?,https://www.linkedin.com/feed/update/urn:li:activity:7341534482098749441?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Custom-made medical devices in Great Britain,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Device specific vigilance guidance,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Electronic Common Technical Document (eCTD) submissions update,https://www.linkedin.com/feed/update/urn:li:activity:7340980885329973248?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Field safety notices: guidance for manufacturers,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: examples of reportable incidents,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: periodic safety update report,https://www.linkedin.com/feed/update/urn:li:activity:7341718273568174080?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Medical devices: post-market surveillance,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: post-market surveillance requirements,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: get scientific advice from MHRA,https://www.linkedin.com/feed/update/urn:li:activity:7340978853525229568?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,The Innovative Devices Access Pathway (IDAP),
23. June 2025,"MEDSAFE,New Zealand",Consultation,Guideline on the Bioequivalence of medicines,https://www.linkedin.com/feed/update/urn:li:activity:7340270643822690304?  
23. June 2025,Ministry of Food and Drug Safety of Republic of Korea,Report,"MFDS,the 2024 Medical Device Approval Report",https://www.linkedin.com/feed/update/urn:li:activity:7341773241566289920?
23. June 2025,South African Health Products Regulatory Authority,Guidance,Regulatory Information Management System Technical Files Website Upload,https://www.linkedin.com/feed/update/urn:li:activity:7340253705310535682?
23. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
23. June 2025,"Therapeutic Goods Administration (TGA),Australia",Report,Action Plan for Medical Devices - Final Progress Report Card: December 2024,https://www.linkedin.com/feed/update/urn:li:activity:7340241744812228608?
23. June 2025,USA Food & Drug Administration FDA,Guidance,ANDAs:Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7340247741014441984?
23. June 2025,USA Food & Drug Administration FDA,Guidance,Post-Warning Letter Meetings Under GDUFA,https://www.linkedin.com/feed/update/urn:li:activity:7341703063348371456?
16. June 2025,ANVISA Brazil,Regulation,"Ordinance GM/MS No. 6,931,of June 4,2025",https://www.linkedin.com/feed/update/urn:li:activity:7339185196732178433?
16. June 2025,European Commission,Guidance,Health Technology Assessment Regulation Capacity Building,https://www.linkedin.com/feed/update/urn:li:activity:7338228815891951616?
16. June 2025,European Commission,Regulation,Master UDI-DI for contact lenses,https://www.linkedin.com/feed/update/urn:li:activity:7339168492744585216?
16. June 2025,European Commission,News,COMBINE programme launched a pilot for clinical trials and performance studies,
16. June 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÃ‚(PRAC) 2 5 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7336725535617671168?
16. June 2025,European Medicines Agency,Report,Annual Report 2024,https://www.linkedin.com/feed/update/urn:li:activity:7338789074402492416?
16. June 2025,European Medicines Agency,Guidance,The summary-of-product-characteristics guideline and paediatric aspects,https://www.linkedin.com/feed/update/urn:li:activity:7339177993153531904? 
16. June 2025,European Medicines Agency,Newsflash,CTIS newsflash 10 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7339177536649617408?
16. June 2025,International Council for Harmonisation,Guidance,ICH E21 Step 2 Presentation Now Available,https://www.linkedin.com/feed/update/urn:li:activity:7339331566638145538? 
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,New Medical Devices Post-Market Surveillance requirements,https://www.linkedin.com/feed/update/urn:li:activity:7337863886689169408?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,User Reference Guide MORE Incident Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7337895160732676098?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Documentation data requirements under the new PMS regulations,https://www.linkedin.com/feed/update/urn:li:activity:7337156496515850241?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Borderlines with medical devices and other products in Great Britain,https://www.linkedin.com/feed/update/urn:li:activity:7338084045488095232?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Risk minimisation measures for medicines,https://www.linkedin.com/feed/update/urn:li:activity:7338088704818774017?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage your authorisation,report safety issues",https://www.linkedin.com/feed/update/urn:li:activity:7338093138969829377?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Decentralised manufacture hub,https://www.linkedin.com/feed/update/urn:li:activity:7338213329611485184?
16. June 2025,Medical Device Single Audit Program MDSAP,Procedure,Auditing Organization (AO) Application For Recognition Procedure,
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Borderline Products In ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339239664253390848?
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Classification of Medical Devices in ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339237972375945218?
16. June 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Guidance,Classification and Definition of IVD Reagents Related to NGS (No. 22 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7339194323520876544?
16. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
16. June 2025,Swissmedic,Guidance,Export Certificates,
16. June 2025,Swissmedic,Guidance,Criteria Annexes 4Ã¢â‚¬â€œ10 KPTPO,
16. June 2025,Team AB,Information,PMS Plan to comply with the GB PMS Requirements 16. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7337156496515850241?
16. June 2025,USA Food & Drug Administration FDA,Report,Office of Clinical Pharmacology (OCP) 2024 Annual Report,https://www.linkedin.com/feed/update/urn:li:activity:7339385697314787328?
16. June 2025,USA Food & Drug Administration FDA,Guidance,ST&F Manual of Policies and Procedures (MAPP),https://martincking.github.io/Standards-Selector/?dropdownwindow=FDA&designation=&title=Good%20Review%20Practices:%20Standard%20Safety%20Tables%20and%20Figures&abstract=
16. June 2025,USA Food & Drug Administration FDA,Guidance,ST&F Integrated Guide,https://martincking.github.io/Standards-Selector/index.html?dropdownwindow=FDA&designation=&title=Standard%20Safety%20Tables%20and%20Figures%20ST&F%20Integrated%20Guide&abstract=
16. June 2025,USA Food & Drug Administration FDA,Guidance,OCMQ Manual of Policies and Procedures (MAPP),https://martincking.github.io/Standards-Selector/?dropdownwindow=FDA&designation=&title=OCMQ%20Manual%20of%20Policies%20and%20Procedures%20(MAPP)&abstract=
16. June 2025,USA Food & Drug Administration FDA,Report,Office of Clinical Pharmacology (OCP) 2024 Annual Report,https://www.linkedin.com/feed/update/urn:li:activity:7339385697314787328?
16. June 2025,USA Food & Drug Administration FDA,Newsletter,"FDA Regulatory Science Newsletter,Issue 1 of 2025,published by the U.S. Food and Drug Administration (FDA)",https://www.linkedin.com/feed/update/urn:li:activity:7339597414397341698?
16. June 2025,International Council for Harmonisation,Guidance,ICH E21 Step 2 PresentationÃ‚Inclusion of Pregnant and Breastfeeding Individuals in Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7339331566638145538? 
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Borderline Products in ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339239664253390848?
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Classification of Medical Devices in ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339237972375945218?
16. June 2025,NMPA-National Medical Products Administration,Guidance,Classification and Definition of In Vitro Diagnostic Reagents Related to Next-Generation Gene Sequencing (No. 22 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7339194323520876544?
16. June 2025,ANVISA Brazil,Regulation,"Ordinance GM/MS No. 6,931,of June 4,2025",https://www.linkedin.com/feed/update/urn:li:activity:7339185196732178433?
16. June 2025,European Medicines Agency,Guidance,The summary-of-product-characteristics guideline and paediatric aspects,https://www.linkedin.com/feed/update/urn:li:activity:7339177993153531904? 
16. June 2025,European Medicines Agency,Newsflash,CTIS newsflash 10 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7339177536649617408?
16. June 2025,European Commission,Regulation,Assignment of Unique Device Identifiers for contact lenses,https://www.linkedin.com/feed/update/urn:li:activity:7339168492744585216?
16. June 2025,European Medicines Agency,Report,ANNUAL REPORT 2024,https://www.linkedin.com/feed/update/urn:li:activity:7338789074402492416?
16. June 2025,European Commission,Guidance,HTAR Capacity Building Programme,https://www.linkedin.com/feed/update/urn:li:activity:7338228815891951616?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Decentralised manufacture hub,https://www.linkedin.com/feed/update/urn:li:activity:7338213329611485184?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage your authorisation,report safety issues",https://www.linkedin.com/feed/update/urn:li:activity:7338093138969829377?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Risk minimisation measures for medicines,https://www.linkedin.com/feed/update/urn:li:activity:7338088704818774017?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Borderline products: medical devices and other products,https://www.linkedin.com/feed/update/urn:li:activity:7338084045488095232?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Documentation for implementation of data requirements under the new Post-Marketing Surveillance regulations,https://www.linkedin.com/feed/update/urn:li:activity:7337900224922705920?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,MORE Registrations - user reference guide,https://www.linkedin.com/feed/update/urn:li:activity:7337895160732676098?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,MHRA guidance on new Medical Devices Post-Market Surveillance requirements,https://www.linkedin.com/feed/update/urn:li:activity:7337863886689169408?
16. June 2025,European Medicines Agency,Meeting,Meeting highlights from the Pharmacovigilance Risk Assessment Committee () 2-5 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7336725535617671168?
16. June 2025,Team AB,Information,Have you generated your PMS Plan to comply with the GB PMS Requirements?,https://www.linkedin.com/feed/update/urn:li:activity:7337156496515850241?
9. June 2025,ANVISA Brazil,Guidance,Medicines Market Regulation Chamber (CMED) approves internal regulations,
9. June 2025,Council for International Organizations of Medical Sciences,Guidance,Glossary of ICH terms and definitions,
9. June 2025,European Commission,Template,Manufacturer Incident Report (MIR) template version 7.3.1 SB10449 Update,
9. June 2025,European Data Protection Board,Guidance,Fundamentals of Secure AI Systems with Personal Data,
9. June 2025,European Medicines Agency,Guidance,IDMP Process for the electronic submission of medicinal product Information,
9. June 2025,European Medicines Agency,Consultation,herbal medicinal products used in children and adolescents,
9. June 2025,European Medicines Agency,Consultation,ICH E21 inclusion of pregnant and breastfeeding individuals in clinical trials,
9. June 2025,European Medicines Agency,Guidance,"On-boarding - Substance,Product,Organisation and Referentials (SPOR)",
9. June 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification monthly report of activities: End of May 2025,
9. June 2025,"Health Sciences Authority (HSA),Singapore",Guidance,SHARE for Medical Devices Industry Briefing Session,
9. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulatory considerations for therapeutic use of bacteriophages in the UK,
9. June 2025,MedTech Europe,Report,Decarbonising Healthcare: How a Competitive MedTech Industry Can Contribute,
9. June 2025,McKinsey & Company,Article,Scaling gen AI in the medtech industry,
9. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
9. June 2025,Swissmedic,Guidance,Product Information for Human Medicinal Products,
9. June 2025,Swissmedic,Guidance,Formal Requirements for Submissions,
9. June 2025,Swissmedic,Guidance,Time Limits for Authorisation Applications,
9. June 2025,Swissmedic,Guidance,Temporary Authorisation for Human Medicinal Products,
9. June 2025,Swissmedic,Guidance,Immunological Veterinary Medicinal Products in Epizootic Outbreaks,
9. June 2025,Swissmedic,Guidance,Product Information for Veterinary Medicinal Products,
9. June 2025,Swissmedic,Guidance,Instructions for Filling the eDok_KLV Folder Structure,
9. June 2025,Swissmedic,Guidance,Submission of Clinical Trials,
9. June 2025,Swissmedic,Guidance,Clinical Trial Application Dossier,
9. June 2025,Swissmedic,Guidance,Amendments in Clinical Trials,
9. June 2025,Swissmedic,Guidance,eIAM Portal Administrator,
9. June 2025,USA Food & Drug Administration FDA,Guidance,M13B Bioequivalence for Immediate-Release Solid Oral Dosage Forms,
9. June 2025,USA Food & Drug Administration FDA,News,FDA Launches Agency-Wide AI Tool,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Transfer of a Premarket Notification (510(k)) Clearance ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ Questions and Answers,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Raw Data for Safety and Effectiveness Studies,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Over-the-Counter Monograph Procedure for Minor Changes C001,
9. June 2025,USA Food & Drug Administration FDA,Guidance,M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Hernia Mesh Package Labeling Recommendations,
2. June 2025,ANVISA Brazil,Guidance,Manual de uso do SIUD Sistema de Identificanica de Dispositivos dicos,
2. June 2025,Council for International Organizations of Medical Sciences,Consultation,Benefit-risk balance for medicinal products,
2. June 2025,Egyptian Drug Authority,Consultation,ICH Q1 Draft Guideline & Step 2,
2. June 2025,Egyptian Drug Authority,Consultation,Bioequivalence studies for generic Veterinary medicinal products,
2. June 2025,European Commission,Presentation,"EUDAMED Workshop 21 May 2025 - Stuttgart,Germany",
2. June 2025,European Commission,Consultation,Clinical assessments of medical devices & IVDs at the Union level,
2. June 2025,European Commission,Proposal,EMDN Helpdesk Officially live,
2. June 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use‚(CHMP) 19-22 May 2025,
2. June 2025,European Medicines Agency,Guidance,Quality of medicines questions and answers: Part 2,
2. June 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,How to read a CEP,
2. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
2. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing and Access Pathway (ILAP),
2. June 2025,MedTech Europe,Guidance,Practical guide to the use of the European Medical Device Nomenclature (EMDN),
2. June 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
2. June 2025,Swissmedic,Guidance,Incident economic operators,
2. June 2025,Swissmedic,Guidance,Marketing Authorisation for Global Health Products MAGHP Procedure,
2. June 2025,Swissmedic,Guidance,Amendment to GMP compliance by foreign manufacturers,
2. June 2025,"Therapeutic Goods Administration (TGA),Australia",News,GMP Clearance: Backlog reduction strategy commencing 1 July 2025,
2. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Adoption of International Scientific Guidelines in Australia,
2. June 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Advertising to health professionals so that consumer rules do not apply,
2. June 2025,USA Food & Drug Administration FDA,Guidance,Electronic Submission Template for Medical Device Q-Submissions,
2. June 2025,USA Food & Drug Administration FDA,Guidance,Requests for Feedback and Meetings: The Q-Submission Program,
2. June 2025,USA Food & Drug Administration FDA,Guidance,Replacing Color Additives in Approved or Marketed Drug Products,
26. May 2025,ANVISA Brazil,Guidance,National Guideline for Antimicrobial Management in Neonatology Services,
26. May 2025,European Commission,Presentation,Health technology assessment for patients and clinical experts,
26. May 2025,European Commission,Consultation,Establishment of an expert panel on orphan and paediatric devices,
26. May 2025,European Commission,Proposal,Simplify several EU regulations (GDPR etc.) to assist small medium enterprises,
26. May 2025,European Medicines Agency,Newsflash,CTIS newsflash ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ 16 May 2025,
26. May 2025,European Medicines Agency,Guidance,"SOP - Validation,Publication,& Maintenance of real-world data sources & studies",
26. May 2025,European Medicines Agency,Guidance,Questions and answers for marketing authorisation on nitrosamine impurities,
26. May 2025,European Medicines Agency,Guidance,Data Protection Notice For the Organisation Management System (OMS),
26. May 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,"Guide to the preparation,use and quality assurance of blood components",
26. May 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,Registration of Processes under Article 61(5) of the Clinical Trial Regulation,
26. May 2025,"Health Products Regulatory Authority (HPRA),Ireland",Form,Application for the Register for Exemption,
26. May 2025,"Health Sciences Authority (HSA),Singapore",Consultation,Exemption from Registration Requirements for Artificial Intelligence ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ SAMD,
26. May 2025,International Council for Harmonisation,Meeting,"ICH Assembly Meeting,Madrid,Spain,May 2025",
26. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Using control arms based on real-world data to support regulatory decisions,
26. May 2025,Medicines and Healthcare products Regulatory Agency,Regulation,The Medical Devices (Amendment) (Great Britain) Regulations 2025,
26. May 2025,Medical Device Single Audit Program MDSAP,Documents,MDSAP Documents for May 2025,
26. May 2025,Pharmacy and Poisons Board (PPB) of Kenya,Guidance,Look-alike Packaging of Health Products and Technologies,
26. May 2025,Sedgwick,Report,Recall Index Report United States edition Q1 2025,
26. May 2025,Sedgwick,Report,Recall Index Report European Edition Q1 2025,
26. May 2025,South African Health Products Regulatory Authority,Guidance,Questions and Answers: Licensing of Medical Device Establishments,
26. May 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
26. May 2025,Swissmedic,Guidance,Urgent amendment to the Swiss Pharmacopoeia,
26. May 2025,Swissmedic,Guidance,"Notifications according to Article 41,MPLO",
26. May 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,GMP clearance application and submission user guide,
26. May 2025,World Health Organisation WHO,Guidance,Transforming the paediatric medicines ecosystem: strategic roadmap 2025ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“2030,
19. May 2025,ANVISA Brazil,Guidance,Second edition of Q&A on RDC 894/2024 Cosmetovigilance,
19. May 2025,ANVISA Brazil,Newsletter,Post-Market Monitoring Newsletter - 1st Edition/2025,
19. May 2025,Egyptian Drug Authority,Guidance,"""WhatsApp"" service to facilitate communication with companies and factories",
19. May 2025,European Commission,Guidance,AI Literacy - Questions & Answers,
19. May 2025,European Commission,Survey,Results of the 12th NB survey,
19. May 2025,European Commission,Consultation,EU Biotech Act,
19. May 2025,European Medicines Agency,Guidance,IDMP Process for the electronic submission of medicinal product Information,
19. May 2025,European Medicines Agency,Guidance,Plasma Master File (PMF) requirements. Q&A for PMF Holders,
19. May 2025,European Medicines Agency,Guidance,Changes policy on the publication of clinical data - medicinal products,
19. May 2025,European Medicines Agency,Guidance,Policy on the publication of clinical data - medicinal products,
19. May 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report April 2025,
19. May 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,Quality and Safety of Organs for Transplantation,
19. May 2025,European Directorate for the Quality of Medicines & HealthCare,News,Adoption of mycoplasmas general chapter & monographs with latest analytics,
19. May 2025,International Pharmaceutical Excipients Council Federation(IPEC),Guidance,Risk Assessment Guide for Pharmaceutical Excipients,
19. May 2025,International Medical Device Regulators Forum,Guidance,IMDRF Standard Operating Procedures Edition 13 Version 2,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: apply for a parallel import licence,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Consultation,Harmonisation ICH E6 (R3) Guideline,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Register a homeopathic medicine,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,: Medical Devices Post Market Surveillance,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,ManufacturerÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s Online Reporting Environment (MORE) & MORE implementation,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Personalised Medical Devices (TR-009),
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Overview of the Medical Device Administrative Control System (GN-01),
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Definitions & Abbreviations MDACS (GN-00),
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Software Medical Devices and Cybersecurity  (TR-007) Update,
19. May 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
19. May 2025,Swissmedic,Guidance,CH Guide Manufacturer Incident Report (MIR),
19. May 2025,Swissmedic,Guidance,Cannabis fÃƒÆ’Ã‚Â¼r medizinische Zwecke,
19. May 2025,Swissmedic,Guidance,Authorisation of co-marketing medicinal product,
19. May 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Regulatory requirements for in vitro diagnostic (IVD) companion diagnostics (CDx),
12. May 2025,Egyptian Drug Authority,Guidance,Quality Module for Human Pharmaceuticals submitted for Re-registration,
12. May 2025,Egyptian Drug Authority,Guidance,Provision of a new service through the Department of Medical Supplies Variables,
12. May 2025,European Commission,Template,Manufacturer Incident Report (MIR) template version 7.3.1,
12. May 2025,European Commission,Meeting,Pharmaceutical Committee 102nd Meeting,
12. May 2025,European Data Protection Board,Letter,Simplification of record-keeping: EDPB and EDPS adopt letter to EU Commission,
12. May 2025,European Medicines Agency,Guidance,Policy on access to EudraVigilance data for medicinal products for human use,
12. May 2025,European Medicines Agency,Guidance,Product Management Service (PMS) - (ISO) standards for (IDMP) in Europe,
12. May 2025,European Medicines Agency,Guidance,"SOPs for assignment and renewal of micro-,SME enterprise status",
12. May 2025,European Medicines Agency,Guidance,NDSG workplan 2025-2028 Data and AI in medicines regulation,
12. May 2025,European Medicines Agency,Consultation,Part IV Guidelines on Good Manufacturing Practice specific to ATMPs,
12. May 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee‚(PRAC) 5 - 8 May 2025,
12. May 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,Validation of eCTD submissions for CEP applications,
12. May 2025,ISO (International Organization for Standardization),Standards,"ISO Update April 1,2025 to May 1,2025",
12. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
12. May 2025,Medicines and Healthcare products Regulatory Agency,Consultation,M13B Bioequivalence for Immediate Release Solid Oral Dosage Forms,
12. May 2025,MedTech Europe,Response,Towards a Revised EU Regulatory Framework for Medical Devices,
12. May 2025,South African Health Products Regulatory Authority,Guidance,"SAHPRA Engagement Portal ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ Variation,Renewal and Response Applications",
12. May 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
12. May 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Using the 'TGA assessed' claim on medicine labels,
12. May 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Understanding regulation of custom-made medical devices,
12. May 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Understanding specified articles in personalised medical devices regulation,
12. May 2025,USA Food & Drug Administration FDA,Guidance,Reduce the Risk of Disease Agents Associated with Sepsis by Human Cells,
12. May 2025,USA Food & Drug Administration FDA,Guidance,Reduce the Risk of Mycobacterium tuberculosis (Mtb) by Human Cells,
12. May 2025,USA Food & Drug Administration FDA,News,Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities,
12. May 2025,USA Food & Drug Administration FDA,News,First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout,
5. May 2025,ANVISA Brazil,Report,2024 Management Report,
5. May 2025,Council for International Organizations of Medical Sciences,Guidance,Severe cutaneous adverse reactions (SCAR),
5. May 2025,Council for International Organizations of Medical Sciences,Report,Artificial intelligence in pharmacovigilance,
5. May 2025,European Commission,Info session,CommissionÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s proposal for a Critical Medicines Act,
5. May 2025,European Commission,Update,Notified Body Update (50) Active MDR (17) IVDR 1 Withdrawn,
5. May 2025,European Medicines Agency,Newsflash,CTIS newsflash ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ 29. April 2025,
5. May 2025,European Medicines Agency,Update,CTIS Simplification Task Force: topics for analysis,
5. May 2025,European Medicines Agency,Paper,For a Reflection Paper on a tailored clinical approach in Biosimilar development,
5. May 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,NDS Web Extranet,
5. May 2025,Medical Device Authority Malaysia,Guidance,Advice Use of Spare Parts for Medical Device Maintenance Purposes,
5. May 2025,Medical Device Authority Malaysia,Guidance,Medical Device for the Purpose of Export Only,
5. May 2025,Medical Device Authority Malaysia,Guidance,Unregistered Medical Devices Under Special Access Exemption Application,
5. May 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Standards,"The ""Quality Management Standards for Online Sales of Medical Devices""",
5. May 2025,Regulatory Affairs Professionals Society (RAPS),Publication,SaMD Applicable requirements for market entry in the EU and US,
5. May 2025,Swiss Federal Council,News,The Federal Council defines guidelines for expanding the supply of medical devices,
5. May 2025,Swissmedic,Forms,Swissmedic Forms for April 2025,
5. May 2025,Swissmedic,Guidance,In-house medicinal product,
5. May 2025,Swissmedic,Guidance,Products containing cannabidiol,
5. May 2025,Swissmedic,Guidance,Formal Requirements,
5. May 2025,Swissmedic,Guidance,GMP compliance by foreign manfacturers,
5. May 2025,Swissmedic,Guidance,Authorisation of Asian medicinal products,
5. May 2025,Swissmedic,Guidance,Authorisation for homeopathic and anthroposophic medicinal products,
5. May 2025,Swissmedic,Guidance,Parallel Import of a human medicinal product according,
5. May 2025,USA Food & Drug Administration FDA,Report,FY 2024 GDUFA Science and Research Report,
5. May 2025,USA Food & Drug Administration FDA,Guidance,Registration & Listing of Cosmetic Product Facilities and Products,
28. April 2025,ANVISA Brazil,Guidance,Implementation of a Quality Management System (QMS) SNVS,
28. April 2025,"Cofepris,Mexico",Regulation,NOM-241-SSA1-2025 Good Manufacturing Practices for Medical Devices,
28. April 2025,"Cofepris,Mexico",Guidance,Questions & Answers  NOM-241-SSA1-2025,
28. April 2025,Drug Regulatory Authority of Pakistan,Guidance,DRAP-PSW Gateway: Online Application  for Pharmaceutical Export Certificates,
28. April 2025,Egyptian Drug Authority,Guidance,Stability Studies Review and Evaluation Time Frame Year 2025,
28. April 2025,Egyptian Drug Authority,Guidance,Link for the completion of the permissible stability studies,
28. April 2025,Egyptian Drug Authority,Consultation,Guideline for Good Clinical Practice E6(r3),
28. April 2025,European Commission,Update,Notified Body Update (50) Active MDR (15) IVD 1 Withdrawn,
28. April 2025,European Commission,Guidance,EUDAMED Release notes Playground v 3.11.0 2025,
28. April 2025,European Data Protection Board,Report,Annual Report 2024 Protecting Personal Data in a Changing Landscape,
28. April 2025,European Medicines Agency,Guidance,Business Process Descriptions,
28. April 2025,European Medicines Agency,Report,"Industry stakeholders and EU network experts surveys,fostering innovation",
28. April 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2025,
28. April 2025,European Directorate for the Quality of Medicines & HealthCare,News,EPC adopts cutting-edge HTS chapter,
28. April 2025,Health Canada,Guidance,Updated: Filing submissions electronically,
28. April 2025,MedTech Europe,Response,EC Call for evidence on the Life Sciences Strategy,
28. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Option to Apply UK Only Stickers to Medicines Expires 30. June 2025,
28. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
28. April 2025,National Institute of Standards and Technology (NIST),Consultation,"NIST Updates Privacy Framework,Tying It to Recent Cybersecurity Guidelines",
28. April 2025,Swissmedic,Forms,Swissmedic Forms for April 2025,
28. April 2025,Swissmedic,Consultation,ICH Guideline M13B Bioequivalence Immediate-Release Solid  Dosage Forms,
28. April 2025,World Health Organisation WHO,Guidance,Implementing Patient Blood Management to Improve Global Blood Health Status,
21. April 2025,ANVISA Brazil,Guidance,Procedural instruction for registration and post-registration of biological products,
21. April 2025,ANVISA Brazil,Guidance,Guidelines on health framework for ultrasensitive PCR parameter,
21. April 2025,ANVISA Brazil,Guidance,Guide on studies of forced degradation in drugs published,
21. April 2025,Egyptian Drug Authority,Guidance,Regulatory Guide on Cosmetic Claims,
21. April 2025,European Commission,News,"""Master UDI-DI Implementation: Updates and Deadlines for Medical Devices",
21. April 2025,European Data Protection Board,Guidance,processing of personal data through blockchain technologies,
21. April 2025,European Medicines Agency,Guidance,Anonymisation of personal in risk management plans,
21. April 2025,European Medicines Agency,Guidance,Q&A how should third party audit(s) be reflected in part C of the QP declaration?,
21. April 2025,European Medicines Agency,Guidance,Q&A Practical arrangements companion diagnostics consultation procedure,
21. April 2025,European Medicines Agency,Guidance,Comments ICH M15 Guideline for Model Informed Drug Development (MIDD),
21. April 2025,European Medicines Agency,Guidance,Procedural advice on paediatric applications,
21. April 2025,European Medicines Agency,Report,surveys on early engagement fostering innovation,
21. April 2025,International Council for Harmonisation,Guidance,Stability Testing of Drug Substances and Drug Products Q1,
21. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Risk minimisation measures for medicines,
21. April 2025,South African Health Products Regulatory Authority,Guidance,Medical Devices and in Vitro Diagnostics Communications to Industry,
21. April 2025,Swissmedic,Forms,: Swissmedic Forms for April 2025,
21. April 2025,Team-NB,Press Release,Classification of IVDÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s intended for screening or detection of SARS-CoV-2,
21. April 2025,Team-NB,Guidance,Team-NB Position Paper on IVDR Certification Process,
21. April 2025,Team-NB,Guidance,Submission of Technical Documentation under Annex II and III of MDR 2017/745,
21. April 2025,Team-NB,Position Paper,European Artificial Intelligence Regulation V2,
21. April 2025,World Health Organisation WHO,Report,Expert Committee on Specifications for Pharmaceutical Preparations,
21. April 2025,World Health Organisation WHO,Report,"WHO Drug Information - Volume 39,No. 1",
14. April 2025,ANVISA Brazil,Report,monitoring and intervention in potential risk in health services,
14. April 2025,Central Drugs Standard Control Organization,Regulation,Market Standing Certificate (MSC) & Non-Conviction Certificate (NCC),
14. April 2025,Egyptian Drug Authority,Guidance,Non-sterile local supplies previously traded,
14. April 2025,European Commission,Initiative,AI Continent Action Plan,
14. April 2025,European Commission,Regulation,Harmonized Standards MDR,
14. April 2025,European Commission,Regulation,Harmonized Standards IVDR,
14. April 2025,European Data Protection Board,Guidance,Study on the secondary use of personal data in the context of scientific research,
14. April 2025,European Data Protection Board,Guidance,AI Privacy Risks & Mitigations Large Language Models (LLMs),
14. April 2025,European Medicines Agency,Guidance,Good Manufacturing Practice‚and‚Good Distribution Practice: Q&A,
14. April 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee‚(PRAC) 7- 10- April 2025,
14. April 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report March 2025,
14. April 2025,European Directorate for the Quality of Medicines & HealthCare,Consultation,Pharmeuropa 37.2 just released (54 drafts published),
14. April 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,Good Distribution Practice of Medicinal Products for Human Use,
14. April 2025,International Medical Device Regulators Forum,Guidance,Terms of Reference,
14. April 2025,International Medical Device Regulators Forum,Guidance,IMDRF Standard Operating Procedures,
14. April 2025,ISO (International Organization for Standardization),Standards,"ISO Update March 1,2025 to April 1,2025",
14. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Early Access to Medicines Scheme ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ Overview,
14. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical investigations,
14. April 2025,Medicines and Healthcare products Regulatory Agency,Regulation,Clinical Trials regulations signed into law,
14. April 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Standards,Abolition of Two Medical Device Industry Standards (No. 36 [2025]),
14. April 2025,Swissmedic,Guidance,Expansion of the Swissmedic position paper on real world evidence,
14. April 2025,Swissmedic,Forms,: Swissmedic Forms for April 2025,
14. April 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Understanding labelling and presentation requirements for listed medicines,
14. April 2025,USA Food & Drug Administration FDA,Guidance,Plan to Phase Out Animal Testing for MABs,
14. April 2025,USA Executive Office of the President,Memorandum,"M-25-21,M-25-22 playbook for responsible AI adoption",
7. April 2025,ANVISA Brazil,Guidance,Safety assessment of impurities & degradation products of synthetic drugs,
7. April 2025,Central Drugs Standard Control Organization,Guidance,Draft risk-based classification of Medical Devices: Cardiovascular & Neurological,
7. April 2025,Central Drugs Standard Control Organization,Guidance,Medical Devices FAQ Doc No.:CDSCO/FAQ/MD/01/2024 Addendum No.: 01,
7. April 2025,European Medicines Agency,Guidance,Guideline on the quality aspects of mRNA vaccines,
7. April 2025,European Medicines Agency,Guidance,Linking to electronic product information (ePI) from EU medicine packages,
7. April 2025,European Medicines Agency,Guidance,Scientific Data Requirements for a Plasma Master File 5 Revision 1 & Annexes,
7. April 2025,European Medicines Agency,Template,Request for advice on the clinical development strategy or clinical data,
7. April 2025,European Medicines Agency,Template,Request for advice on the orphan device status from the Expert Panels,
7. April 2025,European Medicines Agency,Guidance,IRIS guide to registration and Research Product Identifier s RPIs,
7. April 2025,European Medicines Agency,Reflection Paper,A tailored clinical approach in biosimilar development,
7. April 2025,European Medicines Agency,Reflection Paper,Real-world data in non interventional studies used to generate evidence.,
7. April 2025,European Medicines Agency,Document,Journey towards a roadmap for regulatory guidance on real-world evidence,
7. April 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,Verification of economic operator registration for medical device inspections,
7. April 2025,International Medical Device Regulators Forum,Consultation,Playbook for Medical Device Regulatory Reliance Programs,
7. April 2025,International Medical Device Regulators Forum,Outcome Statement,"27th Session of the IMDRF 10-14 March 2025 Shibuya,Tokyo,JAPAN",
7. April 2025,International Medical Device Regulators Forum,Guidance,Medical Devices: PMS: National Competent Authority Report Exchange Criteria,
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing and Access Pathway (ILAP),
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Exceptional Use Authorisation,
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Current Fees,
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,National assessment procedure for medicines,
7. April 2025,Medical Device Authority Malaysia,Guidance,Online Product Classification Application Process,
7. April 2025,Medical Device Authority Malaysia,Guidance,Implementation of Validity Period for Product Classification Letter,
7. April 2025,Swissmedic,Guidance,Medical Device Exemption Procedure,
7. April 2025,Swissmedic,Guidance,Packaging for human medicinal products,
7. April 2025,Swissmedic,Guidance,Procedure with prior notification,
7. April 2025,Swissmedic,Guidance,Fast-track authorisation procedure,
7. April 2025,Swissmedic,Guidance,Temporary authorisation for human medicinal products,
7. April 2025,Swissmedic,Forms,Swissmedic Forms for April 2025,
7. April 2025,Saudi Food & Drug Authority,Guidance,ISO 13485 Requirements and Corresponding SFDA-MDS Requirements,
7. April 2025,USA Food & Drug Administration FDA,Guidance,Evaluation of Sex-Specific Data in Medical Device Clinical Studies,
31. March 2025,ANVISA Brazil,Consultation,Database for Unique Identification of Medical Devices,
31. March 2025,ANVISA Brazil,Regulation,Adjustments to the new regulation of medical devices for IVDs,
31. March 2025,European Commission,Presentation,The EU HTA Regulation: Health Technology Developers of Medicinal Products,
31. March 2025,European Medicines Agency,Report,Advice from the Expert Panels to Manufacturers of High Risk Medical Devices,
31. March 2025,European Medicines Agency,Report,Good Manufacturing and Distribution Practice Inspectors Working Group 2024,
31. March 2025,European Medicines Agency,Newsflash,CTIS newsflash ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ 25 March 2025,
31. March 2025,European Medicines Agency,Guidance,Unforeseen variations according to Article 5 of (EC) No 1234/2008,
31. March 2025,European Medicines Agency,Guidance,Post-authorisation procedural advice for users of the centralised procedure,
31. March 2025,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
31. March 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 24-27 March 2025,
31. March 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,Traditional Herbal Medicinal Products Registration Scheme,
31. March 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,Batch-Specific Requests for Human Medicines,
31. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Safety communications medicines,medical devices & other healthcare products",
31. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Medicines: register to manufacture,import or distribute active substances",
31. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Blue Guide: advertising and promoting medicines,
31. March 2025,Medical Device Authority Malaysia,Guidance,Implementation of Medical Device Import Permit,
31. March 2025,Medical Device Authority Malaysia,Guidance,Medical Devices that have been Approved by other Recognized Countries,
31. March 2025,National Institute of Standards and Technology (NIST),Guidance,Guidelines on Mitigating Cyberattacks Against AI,
31. March 2025,Swissmedic,Guidance,Product quality reviews,
31. March 2025,Swissmedic,Template,Example of a product list,
31. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Preparing for Good Clinical Practice (GCP) inspections,
31. March 2025,"Therapeutic Goods Administration (TGA),Australia",Strategic Plan,Access strategic plan: Updated for 2025-2028,
31. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Complying with the Unique Device Identification requirements for medical devices,
31. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Complying with the Unique Device Identification timeframes for medical devices,
31. March 2025,USA Food & Drug Administration FDA,Guidance,FDA Data Standards Catalog,
31. March 2025,USA Food & Drug Administration FDA,Guidance,Study Data Technical Conformance Guide,
31. March 2025,World Health Organisation WHO,Guidance,Ethics and governance of artificial intelligence for health,
24. March 2025,"Access Consortium‚- Australia,Canada,Singapore,Switzerland,UK",Strategic Plan,Strategic Plan 2025-2028,
24. March 2025,European Commission,Guidance,MDCG 2020-16 rev.4 Guidance on IVD Classification Rules - IVDR 2017/746,
24. March 2025,European Medicines Agency,Guidance,Assessment templates and guidance,
24. March 2025,European Medicines Agency,Report,The European medicines agencies network strategy 2028,
24. March 2025,European Medicines Agency,Report,Analysis and summaries of public consultation results,
24. March 2025,European Medicines Agency,Report,2024 Annual Report on EudraVigilance for the European Parliament,
24. March 2025,European Medicines Agency,Guidance,ICH M11 Technical Specification Updated Step 2b,
24. March 2025,European Medicines Agency,Qualification,AI tool to diagnose inflammatory liver disease (MASH) in biopsy samples,
24. March 2025,Health Canada,Guidance,Regulating authorities under the Food and Drugs Act: Overview,
24. March 2025,Health Canada,Guidance,Regulatory enrolment process (REP),
24. March 2025,Health Canada,Guidance,Environmental risk management authorities under the Food and Drugs Act,
24. March 2025,Health Canada,Consultation,Guidance on co-packaged drug products,
24. March 2025,International Council for Harmonisation,Guidance,ICH M11 Step 2b Technical Specification Document & Template Now Available,
24. March 2025,International Council for Harmonisation,Guidance,M13B Bioequivalence for Immediate Release Solid Oral Dosage Forms,
24. March 2025,International Council for Harmonisation,Guidance,ICH electronic Common Technical Document - eCTD v4.0 Step 4,
24. March 2025,Medicines and Healthcare products Regulatory Agency,Collection,Decentralised manufacture hub,
24. March 2025,MedTech Europe,Paper,Submission of Vigilance Reports to Notified Bodies EU MDR & IVDR,
24. March 2025,MedTech Europe,Paper,Future governance of medical technologies in Europe,
24. March 2025,MedTech Europe,Paper,Digitalisation of Technical Documentation,
24. March 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Regulation,Adjusting and Optimizing the Production of Imported Medical Device Products,
24. March 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Standards,Abolishing Two Medical Device Industry Standards (No. 31 [2025]),
24. March 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Notice,2025 Medical Device Industry Standard Formulation and Revision Plan,
24. March 2025,Swissmedic,Standards,Export Certificates,
24. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Proposed changes to IVD medical device classifications and definitions,
24. March 2025,"Therapeutic Goods Administration (TGA),Australia",Report,Performance Report - 2023-24,
24. March 2025,"Therapeutic Goods Administration (TGA),Australia",Report,Performance Reports,
24. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Consent supply,export medical devices that do not meet the Essential Principles",
24. March 2025,USA Food & Drug Administration FDA,Fees,Over-The-Counter Monograph Drug User Fee Program (OMUFA),
17. March 2025,Egyptian Drug Authority,Guidance,Compliance with the application form for trade names for human pharmaceuticals,
17. March 2025,Egyptian Drug Authority,Guidance,Solubility Rate Studies for Imported / Local Human Pharmaceutical Products,
17. March 2025,European Commission,Guidance,Questions and Answers on the Critical Medicines Act,
17. March 2025,European Commission,Fact Sheet,Critical Medicines Act: Improving & securing supply of critical medicines,
17. March 2025,European Commission,Factsheet,EU actions to address medicine shortages and improve security of supply,
17. March 2025,European Medicines Agency,Guidance,Key documents related to the European Shortages Monitoring Platform,
17. March 2025,European Medicines Agency,Guidance,"FAQs How to create,submit and withdraw CTA - CTIS Training - Module 10",
17. March 2025,European Medicines Agency,Guidance,Product Management Service (PMS) roadmap,
17. March 2025,European Medicines Agency,Guidance,Clinical Evaluation Consultation Procedure (CECP) for a drug-eluting stent,
17. March 2025,European Medicines Agency,Guidance,List of Clinical Evaluation Procedures CECP Opinions,
17. March 2025,European Medicines Agency,Guidance,IRIS guide for applicants,
17. March 2025,European Medicines Agency,Newsflash,CTIS newsflash ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ 11. March 2025,
17. March 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report February 2025,
17. March 2025,"Health Sciences Authority (HSA),Singapore",Consultation,Best Practices Guide for Medical Device Cybersecurity,
17. March 2025,ISO (International Organization for Standardization),Standards,"ISO Update February 1,2025 to March 1,2025",
17. March 2025,"MEDSAFE,New Zealand",Policy,Policy Statement on Clinical trials - Protocol clarification letters,
17. March 2025,Department of Health & Social Care,Policy Paper,Government response to the Regulatory Horizons Council,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Footnotes removed referencing Article 8 of EU Regulation 2023/1182,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Certificates of Free Sale Reference Guide,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good clinical practice for clinical trials,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Newsletter,Regulating and evaluating digital mental health technologies,
17. March 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Guidance,Key Points and Judgment Principles for Medical Device Clinical Trials,
17. March 2025,Swissmedic,Guidance,swissdamed Privacy Notice and Terms of Use,
17. March 2025,Swissmedic,Guidance,Collaborative Assessment Procedures Project ORBIS,
17. March 2025,Team-NB,Statement,Certificates with Conditions ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ Team-NB Statement,
17. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Advertising requirements for disease education activities,
17. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Applying to use a restricted representation,
17. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Advertising compliance self assessment checklist,
17. March 2025,USA Food & Drug Administration FDA,Notification,Data Integrity ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ Medical Devices,
10. March 2025,Egyptian Drug Authority,Guidance,Registration of Synthetic Peptides Human Pharmaceutical Products rDNA Origin,
10. March 2025,European Commission,Regulation,Regulation on the European Health Data Space (EHDS),
10. March 2025,European Commission,Guidance,Frequently Asked Questions on the European Health Data Space,
10. March 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2025,
10. March 2025,European Medicines Agency,Guidance,A new clinical trial map of the Clinical Trials Information System,
10. March 2025,European Medicines Agency,Guidance,Regulatory Procedure Management for PLM in IRIS ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ FAQs,
10. March 2025,European Medicines Agency,Guidance,FAQs How to submit an annual safety report and respond to related RFIs,
10. March 2025,European Medicines Agency,Guidance,"FAQs How to create,submit and withdraw a CTA",
10. March 2025,European Union Agency for Cybersecurity (ENISA),Report,ENISA NIS360 2024,
10. March 2025,Health Canada,Guidance,Drug Product Database (DPD) Data Extract,
10. March 2025,International Medical Device Regulators Forum,Guidance,Terminologies-Categorized Adverse Event Reporting: terminology and codes,
10. March 2025,Journal of Medical Device Regulation,Paper,"High-Quality PMCF Surveys Under EU MDR ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“ Planning,Execution & Data Analysis",
10. March 2025,"MEDSAFE,New Zealand",Journal,Prescriber Update Vol. 46. No. 1 - March 2025,
10. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good laboratory practice (GLP) for safety tests on chemicals,
10. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Advanced therapy medicinal products: regulation and licensing in UK,
10. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,UK-wide licensing for human medicines,
10. March 2025,Medical Dictionary for Regulatory Activities,Guidance,MedDRA Latest Version 28.0 and Support Documentation,
10. March 2025,Swissmedic,Guidance,Information of PSUR PBRER submission HMP,
10. March 2025,Swissmedic,Guidance,Authorisation of herbal medicinal products,
10. March 2025,Swissmedic,Guidance,Renewal & discontinuation or change of status (main authorisation/export licence),
10. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Procedure for recalls,product alerts and product corrections (PRAC)",
10. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Medical devices that do not meet the Essential Principles,
10. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Essential Principles: consent for non-compliance,
10. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Consent for medical devices that do not meet the Essential Principles,
10. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Application for consent medical devices that do not meet the Essential Principles,
10. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,"Devices containing medicinal,microbial,recombinant or animal substances",
3. March 2025,ANVISA Brazil,Guidance,New rules for post-market monitoring of cosmetics,
3. March 2025,Egyptian Drug Authority,Guidance,procedures for import of laboratory and diagnostic reagents,
3. March 2025,European Commission,Consultation,"Medical devices,instructions for use may be provided in electronic form",
3. March 2025,European Commission,Guidance,"Fact Sheets,Success Stories,Rare diseases and European Reference Networks",
3. March 2025,European Medicines Agency,Guidance,Centralised procedure for similar biological medicinal products applications,
3. March 2025,European Medicines Agency,Guidance,Marketing Authorisation Application (MAA) Pre-submission interactions form,
3. March 2025,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
3. March 2025,European Medicines Agency,Report,New Approach Methodologies EU-IN Horizon Scanning Report,
3. March 2025,European Medicines Agency,Guidance,Questions and answers for biological medicinal products,
3. March 2025,European Medicines Agency,Guidance,Considerations regarding the implementation of ICH M13A,
3. March 2025,European Medicines Agency,Newsflash,CTIS newsflash - 25 February 2025,
3. March 2025,European Medicines Agency,Guidance,Infographic - Orphan Medicines in the EU,
3. March 2025,Health Canada,Guidance,Submitting risk management plans,
3. March 2025,"Health Products Regulatory Authority (HPRA),Ireland",Guidance,National Scientific and Regulatory Advice,
3. March 2025,International Pharmaceutical Excipients Council Federation(IPEC),Guidance,Third party Audit and Certification Programmes,
3. March 2025,International Pharmaceutical Excipients Council Federation(IPEC),Guidance,Product Development using Quality-by-Design (QbD),
3. March 2025,ISO (International Organization for Standardization),Standards,"ISO Update January 1,2025 to February 1,2025",
3. March 2025,Medicines and Healthcare products Regulatory Agency,Standard,Implementation of medical devices future regime,
3. March 2025,Medicines and Healthcare products Regulatory Agency,Consultation,"Response,Consultation on Medical Devices Regulations: Routes to market",
3. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Guidance on the licensing of biosimilar products,
3. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Advanced therapy medicinal products: regulation and licensing in UK,
3. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Licensing plasma master files and vaccine antigen master files,
3. March 2025,MedTech Europe,Paper,Clinical strategy - pre-submission dialogue between manufacturer and Notified Body,
3. March 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Standards,10 Medical Device Industry Standards (No. 21 [2025]),
3. March 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
3. March 2025,Swissmedic,Guidance,FSCA economic operators,
3. March 2025,"Therapeutic Goods Administration (TGA),Australia",Report,Pharmacovigilance Inspection Program metrics report: January to December 2022,
3. March 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Demonstrating the quality of listed probiotic medicines,
3. March 2025,"Therapeutic Goods Administration (TGA),Australia",Form,Updating organisation administrator,
3. March 2025,USA Food & Drug Administration FDA,Report,Accelerating Rare disease Cures (ARC) Program Annual Report,
3. March 2025,USA Food & Drug Administration FDA,Report,Drug Safety Priorities 2024,
24. February 2025,Central Drugs Standard Control Organization,Form,Draft (IVD-MD) adverse event reporting form for Comments,
24. February 2025,European Commission,Guidance,Expert decision and opinion in the context of the Clinical Evaluation Consultation,
24. February 2025,European Commission,Update,Notified Body Update (13) Active 1 Withdrawn 1 Suspended IVDR,
24. February 2025,European Commission,Newsletter,Medical Devices News,
24. February 2025,European Data Protection Board,Report,Coordinated Supervision Committee Report of Activities 2022-2024,
24. February 2025,European Medicines Agency,Guidance,Product Management Service (PMS) Frequently Asked Questions,
24. February 2025,European Medicines Agency,Guidance,Post-authorisation Procedural Advice for Users of the‚Centralised Procedure,
24. February 2025,European Medicines Agency,Guidance,Checklist for the submission of Type IA and Type,
24. February 2025,European Medicines Agency,Guidance,Biosimilar medicines:marketing authorisation,
24. February 2025,European Medicines Agency,Guidance,Sponsor Handbook Clinical Trials Information System CTIS,
24. February 2025,European Medicines Agency,Guidance,Introductory guide CTIS for SMEs and Academia,
24. February 2025,European Medicines Agency,Guidance,"How to search,view and download a Clinical,Clinical Trial Application",
24. February 2025,European Medicines Agency,Guidance,FAQs Introduction to the Clinical Trials Regulation (EU) No 536/2014,
24. February 2025,European Medicines Agency,Guidance,Data protection notice Clinical Trials Information System (CTIS),
24. February 2025,Health Canada,Guidance,Managing Applications for Medical Device Licences: Overview,
24. February 2025,Health Products Regulatory Authority (HPRA)‚Ireland,Guidance,Certificate of free sale process updates,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Registration of in vitro diagnostic devices with expiring CE certificates,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Reusable or upclassified Class I devices and/or expiring CE certificates,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good Pharmacovigilance Practices that apply to UK MAHs and the MHRA,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Wholesalers & manufacturers guidance - Windsor Framework,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical Investigations,
24. February 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
24. February 2025,Swissmedic,Report,Swissmedic assessment of post-market surveillance,
24. February 2025,Swissmedic,Guidance,Vigilance-Kontaktperson fuer Medizinprodukte,
24. February 2025,Swissmedic,Guidance,Incident Report User,
24. February 2025,Swissmedic,Guidance,Incident Economic Operators,
24. February 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,International Guidelines Adopted in Australia February 2025,
24. February 2025,USA Food & Drug Administration FDA,Guidance,Drug development tool to facilitate clinical trial research on alcohol use disorder,
17. February 2025,Egyptian Drug Authority,Guidance,Adding new distributor(s) to notify the registration of a medical requirement,
17. February 2025,European Commission,Call for Applications,Pilot coordinated assessment for CI/PS,
17. February 2025,European Commission,Guidance,MDCG 2019-6 rev.5 Q&A: Requirements relating to notified bodies,
17. February 2025,European Commission,Infographic,Health Policy Platform (EUHPP) Overview,
17. February 2025,European Medicines Agency,Guidance,Request advice from Expert Panels on clinical investigations and/or development,
17. February 2025,European Medicines Agency,Guidance,The linguistic review process of product information in the centralised procedure,
17. February 2025,European Medicines Agency,Guidance,Implementation strategy of‚Guideline‚M12 on drug interaction studies,
17. February 2025,European Medicines Agency,Consultation,Assessment & reporting of mechanistic models informed drug development,
17. February 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee‚(PRAC) 10-13 February 2025,
17. February 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report January 2025,
17. February 2025,"Federal Office for Information Security,Germany",Report,Security assessment of wearable devices with medical functionalities (SiWamed),
17. February 2025,Swiss Federal Council,Press Release,AI regulation: Federal Council to ratify Council of Europe Convention,
17. February 2025,International‚Electrotechnical‚Commission,Standards,Design Specification for the second edition of IEC 62304,
17. February 2025,International‚Electrotechnical‚Commission,Standards,IEC 62304 2nd Edition Change Rationales,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good Pharmacovigilance Practices that apply to UK MAHs and the MHRA,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Importing investigational medicinal products into UK from approved countries,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Report,MHRA Real-World Evidence Scientific Dialogue Programme,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Digital mental health technology: qualification and classification,
17. February 2025,Medical Device Authority Malaysia,Press release,Achievements Throughout 2023-2024,
17. February 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Consultation,Supervision and Administration of Export Drug Production,
17. February 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Report,China Medical Device Standards Management Annual Report (2024),
17. February 2025,South African Health Products Regulatory Authority,Guidance,Renewal of Human and Veterinary Medicines Requirements and Process,
17. February 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
17. February 2025,Swissmedic,Position Paper,Decentralised clinical trials (DCTs) with medicinal products in Switzerland,
10. February 2025,"Cofepris,Mexico",Consultation,"Registration of a Medical Device,its Modifications and Extensions.",
10. February 2025,Drug Regulatory Authority of Pakistan,Guidance,"Notification regarding Therapeutic Goods (Advertisement) Rules,2025",
10. February 2025,Egyptian Drug Authority,Guidance,"customs processing medical,laboratory supplies,devices,diagnostic reagents",
10. February 2025,European Commission,News,First request submission period for (JSCs) under the HTA Regulation.,
10. February 2025,European Commission,Guidance,"Prohibited artificial intelligence (AI) practices,as defined by the AI Act.",
10. February 2025,European Commission,Guidance,AI system definition to facilitate the first AI Act rules application,
10. February 2025,European Commission,Guidance,MDCG 2025-2 EMDN Update Submissions from 2024,
10. February 2025,European Commission,Guidance,MDCG 2025-3 EMDN Version History,
10. February 2025,European Medicines Agency,Report,Nanotechnology-based medicinal products for human use,
10. February 2025,European Medicines Agency,Guidance,Q&A on (Regulations MDR (EU) 2017/745 and IVDR (EU) 2017/746),
10. February 2025,European Medicines Agency,Guidance,non-clinical and clinical requirements advanced therapy products in clinical trials,
10. February 2025,Health Canada,Guidance,Pre-market guidance for machine learning-enabled medical devices,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Digital mental health technology: qualification and classification,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Consultation,Draft guidance on individualised mRNA cancer immunotherapies,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Regulation,(Amendment) (Modular Manufacture and Point of Care) Regulations 2025,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulations and current approaches to product marking for the GB market,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Decision tree for nanotechnology-based products for medical applications,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage your authorisation,report safety issues",
10. February 2025,Medical Device Authority Malaysia,Guidance,Placement of HIV Self-Test (HIVST) Kit In Malaysia Market,
10. February 2025,Medical Device Authority Malaysia,Guidance,Advertisement of Medical Device,
10. February 2025,South African Health Products Regulatory Authority,Guidance,Approval of a dosimetry service in South Africa,
10. February 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
10. February 2025,Swissmedic,Guidance,Formal Requirements,
10. February 2025,Swissmedic,Guidance,Directory Overview of documents to be submitted,
10. February 2025,Swissmedic,Guidance,Instandhaltung von Medizinprodukten,
10. February 2025,Swissmedic,Guidance,Instructions for filling the eDok_KLV folder structure,
10. February 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Guidance for the use of medicinal cannabis in Australia: Overview,
10. February 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Request to cancel an ARTG entry,
10. February 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,TGA publishes literature review of sunscreen ingredients,
10. February 2025,USA Food & Drug Administration FDA,Guidance,Risk of Transmission of Mycobacterium tuberculosis (Mtb),
10. February 2025,USA Food & Drug Administration FDA,Guidance,Risk of Transmission of Disease Agents Associated with Sepsis,
10. February 2025,USA Food & Drug Administration FDA,Guidance,FAQs: Guidance for Institutional Review Boards and Clinical Investigators,
10. February 2025,USA Food & Drug Administration FDA,Guidance,Institutional Review Board (IRB) Written Procedures,
3. February 2025,Egyptian Drug Authority,Announcement,Importing dental appliances and supplies,
3. February 2025,Egyptian Drug Authority,Guidance,FAQs examination and analysis and accreditation of standard materials.,
3. February 2025,European Commission,Guidance,MDCG 2024-2 Rev.1 Procedures to European Medical Device Nomenclature,
3. February 2025,European Commission,Form,MDCG 2025-1 EMDN Ad hoc procedure form,
3. February 2025,European Commission,Guidance,MDCG 2021-12 Rev.1 FAQ European Medical Device Nomenclature (EMDN),
3. February 2025,European Commission,Guidance,Advice on SARS-CoV-2 on request from the Medical Device Coordination Group,
3. February 2025,European Commission,News,Joint Action on Expertise on Cancer launched,
3. February 2025,European Commission,News,Joint Action on Respiratory Diseases launched,
3. February 2025,European Commission,News,Biotech and Biomanufacturing Hub to support innovative companies,
3. February 2025,European Medicines Agency,Guidance,ICH‚E6‚good clinical practice- Scientific‚guideline,
3. February 2025,European Medicines Agency,Guidance,CTIS public portal: Full trial information,
3. February 2025,European Medicines Agency,Guidance,On the qualification of non-mutagenic impurities,
3. February 2025,European Medicines Agency,Guidance,Procedural advice for post-orphan medicinal product designation activities,
3. February 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use‚(CHMP) 27-30 January 2025,
3. February 2025,International Medical Device Regulators Forum,Guidance,Considerations for Medical Device Software and Software Specific Risk,
3. February 2025,International Medical Device Regulators Forum,Guidance,Good machine learning practice for medical device development,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Supply unlicensed medicinal products (specials),
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Import a human medicine,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Notification of intent to import an unlicensed medicinal product,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing and Access Pathway (ILAP),
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,UK-wide licensing for human medicines: supplementary guidance,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: get scientific advice from MHRA,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Initiatives,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK,
3. February 2025,Department of Health & Social Care,Policy Paper,Design for Life roadmap,
3. February 2025,National Institute for Healthcare & Excellence,News,Medical Devices Access Iniative MMD,
3. February 2025,"MEDSAFE,New Zealand",Guidance,Updates to the Data sheet template and explanatory guide,
3. February 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
3. February 2025,Swissmedic,Guidance,Preparation for blinded dispensing,
3. February 2025,Swissmedic,Guidance,General procedure for foreign governmental inspections in Switzerland,
3. February 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Australian regulatory guidelines for sunscreens (ARGS),
3. February 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Medical device conformity assessment application,
3. February 2025,World Health Organisation WHO,Glossary,"Glossary of health data,statistics and public health indicators",
3. February 2025,World Health Organisation WHO,Report,Clinical research landscape of monoclonal antibodies,
27. January 2025,ANVISA Brazil,Guidance,New rules for post-market monitoring of cosmetics,
27. January 2025,Association for the Advancement of Medical Instrumentation,Standard,ANSI/AAMI EQ56:2024; Standard for a medical equipment management program,
27. January 2025,Association for the Advancement of Medical Instrumentation,Standard,ANSI/AAMI EQ110:2024;Health technology management educational programs,
27. January 2025,Association for the Advancement of Medical Instrumentation,Standard,ANSI/AAMI EQ103:2024; (AEM) program in healthcare delivery organizations,
27. January 2025,Egyptian Drug Authority,Registry,Egyptian drug registry for blood disease drugs,
27. January 2025,Central Drugs Standard Control Organization,Guidance,Validation of Rapid Diagnostics for Pathogen Identification & AST,
27. January 2025,European Commission,Guidance,Scientific consultations on medical devices & in vitro diagnostic medical devices,
27. January 2025,European Data Protection Board,Guidance,Guidelines 01/2025 on Pseudonymisation,
27. January 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee‚(PRAC) 13-16 January 2025,
27. January 2025,European Medicines Agency,Guidance,Specific adverse reaction follow-up questionnaires (Specific AR FUQ),
27. January 2025,European Medicines Agency,Guidance,Product Management Service (PMS) roadmap,
27. January 2025,International Society for Pharmaceutical Engineering (ISPE),Guidance,Evaluation of Pharma Airborne Particle Emissions from Containment Systems,
27. January 2025,International Council for Harmonisation,Guidance,The ICH E6(R3) Introductory Training Presentation is now available,
27. January 2025,Medical Device Authority Malaysia,Consultation,Importation of Medical Device for Personal Use,
27. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: get scientific advice from MHRA,
27. January 2025,Ministry of Food and Drug Safety of Republic of Korea,Guidance,Guideline on Evaluation of New Extended Release(ER) Preparations,
27. January 2025,"Department for Science,Innovation & Technology",Report,AI Opportunities Action Plan,
27. January 2025,"NMPA-National Medical Products Administration,Peoples Republic of China",Consultation,Using Brain-Computer Interface Technology for AI Algorithms,
27. January 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
27. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,International Guidelines Adopted in Australia January 2025,
27. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Use of market authorisation evidence from comparable overseas regulators,
27. January 2025,USA Food & Drug Administration FDA,Guidance,Bioanalytical Method Validation for Biomarkers,
27. January 2025,USA Food & Drug Administration FDA,Report,CDRH Annual Report,
20. January 2025,ANVISA Brazil,Regulation,DCB: new regulatory framework published,
20. January 2025,Central Drugs Standard Control Organization,Guidance,Update of risk based classification for stakeholder comments,
20. January 2025,European Commission,Guidance,Q&As and Flow-Charts on Gradual Roll-Out of EUDAMED,
20. January 2025,European Commission,Communication,Action Plan on the Cybersecurity of Hospitals and Healthcare Providers,
20. January 2025,European Commission,Guidance,Questions and answers on cybersecurity of hospitals and healthcare providers,
20. January 2025,European Commission,Factsheet,Cybersecurity of hospitals and healthcare providers,
20. January 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,European Pharmacopoeia Supplement 11.8 Notification for CEP holders,
20. January 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report December 2024,
20. January 2025,European Medicines Agency,Guidance,Chapter 3.II: XEVPRM User Guidance,
20. January 2025,European Medicines Agency,Guidance,Electronic submission of Article 57(2) data Questions & Answers (Q&As),
20. January 2025,European Medicines Agency,Guidance,Chapter 5: eXtended EudraVigilance Product Report Acknowledgement Message,
20. January 2025,European Medicines Agency,Newsflash,CTIS newsflash 14 January 2025,
20. January 2025,European Medicines Agency,Report,Human Medicines in 2024,
20. January 2025,International Council for Harmonisation,Guidance,ICH E6(R3) Guideline reaches Step 4 of the ICH Process,
20. January 2025,MedTech Europe,Survey,MedTech Europe IVDR & MDR Survey Results 2024,
20. January 2025,MedTech Europe,Paper,EU HTA Regulation & EU Harmonised Assessment for Digital Medical Devices & AI,
20. January 2025,Medicines and Healthcare products Regulatory Agency,Consultation,ICH M15 Guideline for Model Informed Drug Development (MIDD),
20. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,The Medical Devices (Post-market Surveillance Requirements) (Amendment),
20. January 2025,Medicines and Healthcare products Regulatory Agency,Consultation,Vector Copy Number and addition of PCR validation annexes,
20. January 2025,Saudi Food & Drug Authority,Guidance,Regulation and Requirements for Conducting Clinical Trials on Drug,
20. January 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
20. January 2025,Swissmedic,Guidance,Orphan Drug,
20. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,International Guidelines Adopted in Australia January 2025,
20. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Demonstrating the quality of listed probiotic medicines,
20. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Understanding application audit rules for medical devices including (IVDs),
20. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,Transitioning to new manufacturer evidence for (IVDs),
20. January 2025,USA Food & Drug Administration FDA,Guidance,Premarket Approval Application & Device Exemption Modular Review,
20. January 2025,USA Food & Drug Administration FDA,Guidance,Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria,
20. January 2025,USA Food & Drug Administration FDA,Guidance,Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy,
20. January 2025,USA Food & Drug Administration FDA,Publication,"Narrow Therapeutic Index Drugs: FDA Experience,Views,and Operations",
20. January 2025,USA Food & Drug Administration FDA,Agenda,Rare Disease Innovation Hub,
20. January 2025,USA Food & Drug Administration FDA,Report,Accreditation Scheme for Conformity Assessment (ASCA) Annual Report 2024,
13. January 2025,European Commission,Guidance,"MDCG 2023-3 rev.2 Q&A on vigilance terms MDR,IVDR",
13. January 2025,European Commission,Guidance,MDCG 2024-7 rev.1 & Annex  Preliminary assessment review (PAR) form,
13. January 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,Pharmeuropa 37.1 just released,
13. January 2025,European Medicines Agency,Guidance,IRIS guide for applicants,
13. January 2025,European Medicines Agency,Guidance,New Organisation First User EU QPPV/RP or Change of EU QPPV/RP,
13. January 2025,European Medicines Agency,Guidance,Information package for certificates of EMA issued medicinal products,
13. January 2025,ISO (International Organization for Standardization),Standards,"ISO Update December 1,2024 to January 1,2025",
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulation of devices in Northern Ireland,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Qualified person responsible-pharmacovigilance (QPPV) & (PSMF),
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Guidance on pharmacovigilance procedures,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Guidance on MAH and QPPV location,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework Hub,
13. January 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
13. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,International Guidelines Adopted in Australia January 2025,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Communications From Firms to Health Care Providers Q&A,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Pulse Oximeters for Medical Purposes,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Draft Guidance on Artificial Intelligence-Enabled Device Software Functions,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Considerations for AI to Support Regulatory Decision-Making,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Study of Sex Differences in the Clinical Evaluation of Medical Products,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Sex-Specific & Gender-Specific Data in Medical Device Clinical Studies,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Validation of Certain IVD Device for Emerging Pathogens during 564 Emergency,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Accelerated Approval &  Determining a Confirmatory Trial,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Considerations for Including Tissue Biopsies in Clinical Trials,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Section 506j discontinuance or Interruption in Manufacturing of a Device,
13. January 2025,USA Food & Drug Administration FDA,Guidance,"Human Cells,Tissues,and Cellular and Tissue-Based Products (HCT/Ps)",
13. January 2025,USA Food & Drug Administration FDA,Guidance,Developing Drugs for Optical Imaging,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Developing Drugs and Biological Products for Weight Reduction,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Compounding Using Bulk Drug Substances Under Section 503A & 503B,
13. January 2025,USA Food & Drug Administration FDA,Report,CDER: New Drug Therapy Approvals 2024,
6. January 2025,ANVISA Brazil,Guidance,Anvisa concludes the 2nd cycle of review and consolidation of normative acts,
6. January 2025,Egyptian Drug Authority,Guidance,Online Complaints and Interview Requests of the General Directorate of Stability,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework (WF) Guide to Product Categorisation for New Applications,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,UK medicines export and labelling for international regulators,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Sourcing medicines for the UK market,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework Hub,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Exceptions and modifications to the EU guidance on GVP practices,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,150-day assessment for national applications for medicines,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Procedures for UK paediatric investigation plan (PIPs),
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,herbal medicinal products and homeopathic medicinal products,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Renewing marketing authorisations for medicines,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active substances manufactured in GB for use in EEA and NI,
6. January 2025,Swissmedic,Amendment,In Vitro Diagnostic Medical Devices (IVDs) and the Medical Devices Ordinance,
6. January 2025,Swissmedic,Guidance,Optimisation of labelling phase for human medicinal products,
6. January 2025,Swissmedic,Guidance,Procurement of medical devices in healthcare institutions,
6. January 2025,Swissmedic,Guidance,Obligations Economic Operators CH,
6. January 2025,Swissmedic,Guidance,Description of document protection,
6. January 2025,"Therapeutic Goods Administration (TGA),Australia",Guidance,International Guidelines Adopted in Australia,
6. January 2025,USA Food & Drug Administration FDA,Briefing,Combined FDA and Sponsor Oncologic Drugs Advisory Committee,
6. January 2025,USA Food & Drug Administration FDA,Guidance,"Deviations for Clinical Investigations of Drugs,Biological Products,& Devices",
6. January 2025,USA Food & Drug Administration FDA,Guidance,M15 General Principles for Model-Informed Drug Development,
6. January 2025,USA Food & Drug Administration FDA,Guidance,E11A Pediatric Extrapolation,
6. January 2025,USA Food & Drug Administration FDA,Guidance,Advanced Manufacturing Technologies Designation Program,
6. January 2025,USA Food & Drug Administration FDA,Guidance,SOPP 8422: Processing and Review of Trans-BLA Submissions,
6. January 2025,USA Food & Drug Administration FDA,Guidance,Guidance Agenda: CBER Calendar Year 2025,
6. January 2025,USA Food & Drug Administration FDA,Guidance,Considerations for Complying With 21 CFR 211.110,
